IBRX ImmunityBio, Inc. - Common Stock
IBRX 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
IBRX 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
IBRX 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 4 40.0%
- 매수 5 50.0%
- 보유 1 10.0%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
4 명의 애널리스트 · 2026-08-16실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.22 | $-0.09 | -0.13% |
| 2026년 3월 31일 | $-0.08 | $-0.07 | -0.01% |
| 2025년 12월 31일 | $-0.06 | $-0.10 | 0.04% |
| 2025년 9월 30일 | $-0.07 | $-0.11 | 0.04% |
| 2025년 6월 30일 | $-0.10 | $-0.11 | 0.01% |
| 2025년 3월 31일 | $-0.15 | $-0.13 | -0.02% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| IBRX | $2.00B | -5.2 | 668.3% | -310.2% | 71.0% | — |
| IONS | $12.92B | -33.2 | — | — | -68.1% | — |
| SYRE | $2.56B | 10.1 | -62.0% | — | -26.5% | — |
| PCVX | $6.05B | -8.2 | — | — | -26.6% | — |
| IMVT | $5.07B | -9.0 | 229.2% | — | -73.7% | — |
| TWST | $1.71B | -21.6 | 20.3% | -20.6% | -17.0% | — |
| RYTM | $7.19B | -34.4 | 45.8% | -103.6% | -309.1% | — |
| TGTX | $4.63B | 10.8 | 87.3% | 72.6% | 96.7% | — |
| ORKA | $1.48B | -3.3 | — | — | -25.9% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 17
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $113M | $15M | $622.0K | $240.0K | $934.0K | $605.0K | $2M | $47.0K | $45.0K | $44.0K | $236.0K | $641.0K | |
| Cost of Revenue | $753.0K | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| R&D Expense | · | $190M | $232M | $248M | $196M | $140M | $112M | $56M | $42M | $29M | $11M | $2M | |
| SG&A Expense | · | $169M | $130M | $103M | $135M | $71M | $46M | $43M | $57M | $95M | $228M | $5M | |
| Operating Expenses | $369M | $359M | $363M | $352M | $331M | $221M | $158M | $98M | $99M | $125M | $239M | $6M | |
| Operating Income | $-256M | $-344M | $-362M | $-351M | $-330M | $-221M | $-156M | $-98M | $-99M | $-124M | $-239M | $-6M | |
| Interest Expense | $61M | $115M | $129M | $64M | $15M | $9M | $6M | · | $618.0K | $66.0K | $0 | $471.0K | |
| Interest Income | · | · | · | · | · | $1M | $2M | $2M | $4M | $5M | $312.0K | $20.0K | |
| Other Non-op | $-2M | $-15.0K | $-2M | $-736.0K | $193.0K | $1M | $-534.0K | $236.0K | $157.0K | $88.0K | $77.0K | $0 | |
| Pretax Income | $-352M | $-414M | $-584M | $-417M | $-350M | $-226M | $-160M | $-97M | $-97M | $-121M | $-237M | $-6M | |
| Income Tax | $-135.0K | $0 | $-40.0K | $34.0K | $9.0K | $-2M | $-105.0K | $-503.0K | $-493.0K | $-572.0K | $-301.0K | $1.0K | |
| Net Income | $-351M | $-414M | $-583M | $-417M | $-347M | $-222M | $-158M | $-96M | $-96M | $-121M | $-237M | $-6M | |
| EPS (Basic) | $-0.38 | $-0.59 | $-1.15 | $-1.04 | $-0.89 | $-0.59 | $-0.43 | · | · | · | · | · | |
| EPS (Diluted) | $-0.38 | $-0.62 | $-1.15 | $-1.04 | $-0.89 | $-0.59 | $-0.43 | · | · | · | · | · | |
| Shares (Basic) | 919,863,000 | 697,312,000 | 508,636,000 | 399,900,000 | 389,234,156 | 377,067,527 | 366,324,859 | · | · | · | · | · | |
| Shares (Diluted) | 919,863,000 | 700,443,000 | 508,636,000 | 399,900,000 | 389,234,156 | 377,067,527 | 366,324,859 | · | · | · | · | · | |
| EBITDA | $-241M | $-327M | $-344M | $-333M | $-316M | $-82M | $-59M | $-89M | $-94M | $-121M | $1M | · |
대차대조표 29
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $143M | $265M | $105M | $181M | $35M | $76M | $17M | $24M | $8M | $176M | $59M | |
| Short-term Investments | $154M | $6M | $1M | $3M | $136M | $61M | · | · | $104M | $191M | $118M | · | |
| Receivables | $43M | $2M | $0 | · | · | · | · | · | · | · | · | $145.0K | |
| Inventory | $910.0K | $8M | $0 | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $29M | $24M | $26M | $32M | $16M | $14M | $4M | $14M | $4M | $5M | $3M | $124.0K | |
| Other Current Assets | $2M | $1M | $2M | $2M | $3M | $110.0K | $24.0K | $42.0K | $275.0K | $275.0K | $0 | · | |
| Current Assets | $315M | $185M | $294M | $141M | $334M | $112M | $56M | $89M | $132M | $205M | $298M | $59M | |
| PP&E (Net) | $114M | $137M | $146M | $144M | $83M | $73M | $61M | $77M | $77M | $19M | $6M | $211.0K | |
| PP&E (Gross) | $227M | $237M | $230M | $213M | $136M | $114M | $79M | $88M | $81M | $20M | $6M | $257.0K | |
| Accum. Depreciation | $112M | $100M | $84M | $69M | $53M | $42M | $19M | $12M | $4M | $1M | $167.0K | $46.0K | |
| Goodwill | $910.0K | $910.0K | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $13M | $15M | $17M | $20M | $1M | $1M | $0 | $565.0K | $3M | $5M | $7M | $3.0K | |
| Other Non-current Assets | · | $5M | $3M | $5M | $7M | $3M | $4M | $2M | $330.0K | $788.0K | $1M | $409.0K | |
| Total Assets | $502M | $383M | $504M | $362M | $469M | $221M | $143M | $182M | $250M | $317M | $367M | $61M | |
| Accounts Payable | · | · | · | $21M | $11M | $12M | $2M | $3M | $6M | $4M | $2M | $1M | |
| Accrued Liabilities | $47M | $41M | $43M | $42M | $51M | $37M | $5M | $21M | $11M | $6M | $3M | $311.0K | |
| Short-term Debt | · | · | $0 | $432M | · | · | · | · | · | · | · | $265.0K | |
| Current Liabilities | $62M | $55M | $58M | $501M | $369M | $68M | $12M | $27M | $21M | $13M | $6M | $2M | |
| Capital Leases | $33M | $35M | $40M | $48M | $37M | $16M | $11M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | · | $162.0K | $170.0K | · | $0 | $498.0K | $996.0K | $1M | · | |
| Other Non-current Liabilities | $424.0K | $319.0K | $1M | $457.0K | $411.0K | $1M | · | $0 | $255.0K | $240.0K | $0 | · | |
| Total Liabilities | $1.00B | $871M | $1.09B | $812M | $713M | $340M | $22M | $36M | $32M | $24M | $11M | $2M | |
| Total Debt | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Common Stock | $101.0K | $85.0K | $67.0K | $42.0K | $40.0K | $38.0K | $10.0K | $8.0K | $8.0K | $8.0K | $8.0K | · | |
| Retained Earnings | $-3.73B | $-3.38B | $-2.96B | $-2.38B | $-1.96B | $-1.62B | $-662M | $-595M | $-499M | $-387M | $-250M | $-13M | |
| AOCI | $29M | $1M | $10.0K | $183.0K | $4.0K | $122.0K | $-105.0K | $-267.0K | $-381.0K | $-284.0K | $-192.0K | · | |
| Stockholders' Equity | $-500M | $-489M | $-587M | $-447M | $-242M | $-120M | $121M | $146M | $219M | $293M | $356M | $58M | |
| Liabilities + Equity | $502M | $383M | $504M | $362M | $469M | $221M | $143M | $182M | $250M | $317M | $367M | $61M | |
| Shares Outstanding | 1,011,800,008 | 852,904,340 | 670,867,344 | 421,569,115 | 397,830,044 | 382,243,142 | 371,976,995 | 348,677,955 | 79,021,878 | 81,983,937 | 81,311,686 | · |
현금 흐름 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $18M | $19M | $18M | $14M | $13M | $14M | $10M | $6M | $4M | $1M | $36.0K | |
| Stock-based Comp | $37M | $34M | $49M | $40M | $57M | $2M | $3M | $23M | $37M | $74M | $211M | $789.0K | |
| Deferred Tax | $-139.0K | $0 | $-14.0K | $-4.0K | $-8.0K | $-3M | $-8.0K | $-498.0K | $-497.0K | $-575.0K | $-302.0K | $0 | |
| Amort. of Intangibles | · | $2M | $2M | $2M | · | · | $600.0K | $2M | $2M | $3M | $1M | $0 | |
| Other Non-cash | $-6M | $-30M | $149M | $21M | $960.0K | $11M | $-7M | $406.0K | $6M | $5M | $-820.0K | · | |
| Operating Cash Flow | $-305M | $-391M | $-367M | $-338M | $-274M | $-172M | $-152M | $-63M | $-49M | $-39M | $-25M | $-5M | |
| CapEx | $4M | $7M | $31M | $78M | $34M | $2M | $4M | $13M | $35M | $7M | $2M | $235.0K | |
| Investing Cash Flow | $-150M | $-12M | $-30M | $27M | $-85M | $-20M | $19M | $57M | $100M | $-114M | · | · | |
| Stock Issued | · | · | · | $60M | $165M | $86M | $30M | $0 | · | $0 | $0 | $1M | |
| Stock Repurchased | · | · | · | · | $0 | $0 | $3M | $228.0K | $15M | $16M | $5M | $0 | |
| Net Stock Activity | · | · | · | $60M | $165M | $86M | $-501.0K | $-228.0K | $-15M | $-16M | $-5M | · | |
| Financing Cash Flow | $400M | $282M | $558M | $234M | $505M | $151M | $114M | $-771.0K | $-35M | $-16M | · | · | |
| Net Change in Cash | $-54M | $-122M | $161M | $-76M | $146M | $-41M | $-19M | · | $16M | $-168M | $117M | $59M | |
| Taxes Paid | $0 | $15.0K | $8.0K | $2.0K | $9.0K | $8.0K | $3.0K | $4.0K | $3.0K | $2.0K | $1.0K | $1.0K | |
| Free Cash Flow | $-309M | $-398M | $-397M | $-416M | $-308M | $-73M | $-66M | $-76M | $-84M | $-45M | $-28M | · | |
| Levered FCF | $-370M | $-513M | $-527M | $-479M | $-323M | · | · | · | $-84M | $-45M | · | · |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -226.0% | -2334.2% | -58239.5% | -146374.2% | -35361.9% | -82546.0% | -157690.7% | -209338.3% | -220266.7% | -282954.6% | · | · | |
| Net Margin | -310.2% | -2804.8% | -93761.4% | -173569.6% | -37129.6% | -83227.9% | -152997.7% | -204736.2% | -214273.3% | -274565.9% | -100371.2% | · | |
| Pretax Margin | -310.4% | -2805.3% | -93873.3% | -173869.2% | -37456.0% | -83223.4% | -153223.3% | -205806.4% | -215368.9% | -275865.9% | · | · | |
| EBITDA Margin | -212.3% | -2215.2% | -55263.3% | -138765.8% | -33837.5% | -74305.4% | -136732.6% | -189008.5% | -207897.8% | -274756.8% | 623.7% | · | |
| ROA | -79.4% | -93.2% | -134.6% | -100.2% | -100.5% | -62.6% | -40.5% | -44.5% | -34.0% | -35.3% | · | · | |
| ROE | 71.0% | 76.9% | 112.8% | 120.8% | 191.6% | -64.4% | -51.3% | -62.5% | -37.6% | -37.2% | -114.5% | · | |
| ROIC | 51.1% | 70.4% | 61.7% | 78.5% | 136.4% | -78.0% | -56.1% | -67.0% | -45.1% | -42.2% | · | · |
유동성 및 지급능력 4
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | 3.4 | 5.0 | 0.3 | 0.9 | 3.1 | 4.8 | 3.3 | 6.3 | 16.3 | · | · | |
| Quick Ratio | 4.6 | 2.8 | 4.6 | 0.2 | 0.9 | 0.5 | 1.3 | 0.6 | 6.1 | 15.8 | 47.9 | · | |
| Debt / Equity | · | · | 0.0 | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | -4.2 | -3.0 | -2.8 | -5.5 | -22.2 | · | · | · | -160.4 | -1886.4 | · | · |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.2 | 0.0 | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 5.0 | 12.5 | · | · | · | · | · | · | · | · | · | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 668.3% | 2270.6% | 159.2% | -74.3% | 54.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 678.6% | 150.9% | 0.93% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 184.8% | · | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $113M | $15M | $622.0K | $240.0K | $934.0K | $605.0K | $2M | $47.0K | $45.0K | $44.0K | $236.0K | · | |
| Net Income TTM | $-351M | $-414M | $-583M | $-417M | $-347M | $-222M | $-158M | $-96M | $-96M | $-121M | $-237M | · | |
| Market Cap | $2.00B | $2.18B | $3.37B | $2.14B | $2.42B | $1.45B | $373M | $92M | $355M | $469M | · | · | |
| Enterprise Value | · | · | $3.10B | · | · | · | · | · | · | · | · | · | |
| P/E | -5.2 | -4.1 | -4.4 | -4.9 | -6.8 | -22.6 | -8.8 | · | · | · | · | · | |
| P/S | 17.7 | 148.1 | 5414.4 | 8905.6 | 2589.7 | 2395.6 | 169.5 | 1952.0 | 7884.6 | 10657.9 | · | · | |
| P/B | -4.0 | -4.5 | -5.7 | -4.8 | -10.0 | 12.3 | 3.1 | 0.6 | 1.6 | 1.6 | · | · | |
| P / Cash Flow | -6.6 | -5.6 | -9.2 | -6.3 | -8.8 | -20.6 | -6.1 | -1.4 | -7.3 | -12.2 | · | · | |
| P / FCF | -6.5 | -5.5 | -8.5 | -5.1 | -7.9 | -19.8 | -5.7 | -1.2 | -4.2 | -10.4 | · | · | |
| EV / EBITDA | · | · | -9.0 | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | · | -7.8 | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | 4986.0 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -19.2% | -24.2% | -22.9% | -20.5% | -14.6% | -4.4% | -11.3% | · | · | · | · | · |
손익계산서 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $51M | $44M | $38M | $32M | $26M | $17M | $8M | $6M | $1M | $40.0K | $139.0K | $82.0K | $41.0K | $360.0K | $73.0K | $118.0K | |
| Cost of Revenue | $298.0K | $238.0K | $382.0K | $177.0K | $136.0K | $58.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | |
| R&D Expense | · | · | · | · | · | · | · | $50M | $51M | $53M | · | $48M | $53M | $79M | $58M | $72M | |
| SG&A Expense | · | · | · | · | · | · | · | $36M | $49M | $42M | · | $32M | $32M | $33M | $26M | $19M | |
| Operating Expenses | $113M | $114M | $103M | $88M | $98M | $81M | $77M | $86M | $100M | $95M | $86M | $80M | $85M | $112M | $85M | $91M | |
| Operating Income | $-62M | $-70M | $-65M | $-56M | $-71M | $-64M | $-69M | $-80M | $-99M | $-95M | $-85M | $-80M | $-85M | $-112M | $-85M | $-91M | |
| Interest Expense | · | · | $15M | $15M | $15M | $15M | $26M | $29M | $30M | $29M | $32M | $35M | $32M | $30M | $29M | $17M | |
| Other Non-op | $242.0K | $-6M | $-2M | $-187.0K | $-278.0K | $-41.0K | $10.0K | $12.0K | $-17.0K | $-20.0K | $-71.0K | $-1M | $-28.0K | $-1M | $-923.0K | $6.0K | |
| Pretax Income | $-230M | $-633M | $-62M | $-67M | $-92M | $-130M | $-59M | $-86M | $-135M | $-134M | $-233M | $-96M | $-138M | $-117M | $-108M | $-111M | |
| Income Tax | $0 | $9.0K | $-135.0K | $-35.0K | $269.0K | $-234.0K | $0 | $0 | $0 | $0 | $-40.0K | $0 | $0 | $0 | $34.0K | $0 | |
| Net Income | $-230M | $-633M | $-62M | $-67M | $-93M | $-130M | $-59M | $-86M | $-135M | $-134M | $-233M | $-96M | $-138M | $-116M | $-108M | $-111M | |
| EPS (Basic) | $-0.22 | $-0.62 | $-0.06 | $-0.07 | $-0.10 | $-0.15 | $-0.07 | $-0.12 | $-0.20 | $-0.20 | $-0.37 | $-0.19 | $-0.32 | $-0.27 | $-0.26 | $-0.28 | |
| EPS (Diluted) | $-0.22 | $-0.62 | $-0.06 | $-0.07 | $-0.10 | $-0.15 | $-0.08 | $-0.14 | $-0.20 | $-0.20 | $-0.37 | $-0.19 | $-0.32 | $-0.27 | $-0.26 | $-0.28 | |
| Shares (Basic) | 1,050,070,000 | 1,026,874,000 | -1,768,116,000 | 946,601,000 | 888,216,000 | 853,162,000 | -1,358,352,000 | 695,895,000 | 686,938,000 | 672,831,000 | -855,577,142 | 498,375,000 | 437,456,657 | 428,381,485 | -796,033,778 | 400,059,707 | |
| Shares (Diluted) | 1,050,070,000 | 1,026,874,000 | -1,768,116,000 | 946,601,000 | 888,216,000 | 853,162,000 | -1,357,287,000 | 697,961,000 | 686,938,000 | 672,831,000 | -855,577,142 | 498,375,000 | 437,456,657 | 428,381,485 | -796,033,778 | 400,059,707 | |
| EBITDA | $-62M | $-65M | · | $-56M | $-71M | $-61M | · | $-80M | $-99M | $-91M | · | $-80M | $-85M | $-107M | · | $-91M |
대차대조표 28
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $76M | $205M | $88M | $60M | $138M | $61M | $143M | $112M | $130M | $133M | $265M | $178M | $44M | $88M | $105M | $104M | |
| Short-term Investments | $282M | $176M | $154M | $198M | $16M | $931.0K | $6M | $18M | $88M | $37M | · | $12M | $2M | $3M | · | $7M | |
| Receivables | $53M | $43M | $43M | $32M | $22M | $17M | $2M | $4M | $1M | · | · | · | · | · | · | · | |
| Inventory | $2M | $547.0K | $910.0K | $7M | $7M | $8M | $8M | $2M | $2M | · | · | · | · | · | · | · | |
| Prepaid Expense | · | $28M | $29M | $33M | $26M | $22M | $24M | $26M | $21M | $23M | · | $23M | $19M | $21M | · | $31M | |
| Other Current Assets | · | $3M | $2M | $3M | $2M | $2M | $1M | $1M | $480.0K | $3M | · | $4M | $5M | $4M | · | $3M | |
| Current Assets | $439M | $453M | $315M | $329M | $208M | $109M | $185M | $163M | $243M | $196M | · | $215M | $67M | $113M | · | $143M | |
| PP&E (Net) | $114M | $113M | $114M | $130M | $133M | $135M | $137M | $139M | $142M | $144M | · | $152M | $151M | $154M | · | $130M | |
| PP&E (Gross) | · | $229M | $227M | $239M | $239M | $238M | $237M | $235M | $234M | $232M | · | $233M | $229M | $228M | · | $195M | |
| Accum. Depreciation | · | $116M | $112M | $109M | $106M | $103M | $100M | $96M | $92M | $88M | · | $81M | $78M | $73M | · | $65M | |
| Goodwill | · | $910.0K | $910.0K | $910.0K | $910.0K | $910.0K | $910.0K | $910.0K | · | · | · | · | · | · | · | · | |
| Intangibles | · | $12M | $13M | $14M | $14M | $14M | · | $15M | $16M | $17M | · | $18M | $19M | $20M | · | $20M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $4M | $3M | $3M | · | $3M | $4M | $5M | · | $5M | |
| Total Assets | $629M | $647M | $502M | $519M | $402M | $304M | $383M | $365M | $444M | $401M | · | $432M | $291M | $343M | · | $353M | |
| Accounts Payable | · | · | · | · | · | · | · | · | · | · | · | · | · | $34M | · | $20M | |
| Accrued Liabilities | · | $48M | $47M | $44M | $36M | $28M | $41M | $44M | $35M | $33M | · | $65M | $62M | $54M | · | $46M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $482M | · | · | · | |
| Current Liabilities | $77M | $68M | $62M | $57M | $51M | $49M | $55M | $61M | $62M | $54M | · | $90M | $613M | $565M | · | $71M | |
| Capital Leases | $31M | $33M | $33M | $34M | $36M | $33M | $35M | $37M | $36M | $38M | · | $39M | $45M | $46M | · | $50M | |
| Other Non-current Liabilities | $510.0K | $472.0K | $424.0K | $702.0K | $710.0K | $370.0K | $319.0K | $705.0K | $704.0K | $1M | · | $467.0K | $473.0K | $462.0K | · | $569.0K | |
| Total Liabilities | $1.67B | $1.52B | $1.00B | $1.04B | $972M | $894M | $871M | $1.11B | $1.14B | $1.09B | · | $843M | $936M | $875M | · | $782M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $482M | · | · | · | |
| Common Stock | $105.0K | $104.0K | $101.0K | $98.0K | $91.0K | $85.0K | $85.0K | $70.0K | $69.0K | $68.0K | · | $67.0K | $44.0K | $43.0K | · | $40.0K | |
| Retained Earnings | $-4.59B | $-4.36B | $-3.73B | $-3.66B | $-3.60B | $-3.50B | $-3.38B | $-3.32B | $-3.23B | $-3.10B | · | $-2.73B | $-2.63B | $-2.49B | · | $-2.27B | |
| AOCI | $27M | $27M | $29M | $5M | $13M | $20M | $1M | $103.0K | $-8.0K | $-7.0K | · | $792.0K | $-40.0K | $-33.0K | · | $-190.0K | |
| Stockholders' Equity | $-1.05B | $-870M | $-500M | $-524M | $-571M | $-591M | $-489M | $-745M | $-698M | $-692M | · | $-412M | $-642M | $-529M | · | $-427M | |
| Liabilities + Equity | $629M | $647M | $502M | $519M | $402M | $304M | $383M | $365M | $444M | $401M | · | $432M | $291M | $343M | · | $353M | |
| Shares Outstanding | 1,053,221,645 | 1,047,341,146 | 1,011,800,008 | 984,965,179 | 915,625,053 | 853,556,193 | 852,904,340 | 696,831,296 | 691,793,169 | 677,003,411 | 670,867,344 | 667,703,040 | 440,673,897 | 421,569,115 | 421,569,115 | 400,304,106 |
현금 흐름 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | |
| Stock-based Comp | $9M | $8M | $9M | $9M | $10M | $10M | $9M | $7M | $10M | $8M | $13M | $14M | $11M | $11M | $9M | $11M | |
| Amort. of Intangibles | · | · | · | · | $500.0K | $500.0K | · | $500.0K | $500.0K | $500.0K | · | $500.0K | $500.0K | $500.0K | $400.0K | $600.0K | |
| Other Non-cash | · | $545M | · | · | · | $30M | · | · | · | $14M | · | · | · | $16M | · | · | |
| Operating Cash Flow | $-66M | $-75M | $-70M | $-69M | $-80M | $-86M | $-85M | $-99M | $-100M | $-107M | $-115M | $-87M | $-80M | $-84M | $-91M | $-81M | |
| CapEx | $4M | $2M | $903.0K | $741.0K | $1M | $1M | $2M | $3M | $724.0K | $1M | $8M | $6M | $9M | $8M | $19M | $16M | |
| Investing Cash Flow | $-107M | $-32M | $44M | $-181M | $-16M | $4M | $10M | $65M | $-51M | $-36M | $2M | $-16M | $-9M | $-8M | $-19M | $-1M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $47M | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $47M | · | · | |
| Financing Cash Flow | $44M | $224M | $55M | $174M | $173M | $-982.0K | $107M | $16M | $149M | $10M | $201M | $238M | $43M | $77M | $110M | $124M | |
| Net Change in Cash | $-130M | $117M | $28M | $-77M | $77M | $-83M | $32M | $-18M | $-3M | $-132M | $87M | $134M | $-45M | $-16M | $480.0K | $42M | |
| Taxes Paid | · | · | $0 | $0 | $0 | $0 | $0 | $2.0K | $5.0K | $8.0K | $8.0K | $0 | $0 | $0 | $-1.0K | $3.0K | |
| Free Cash Flow | · | $-77M | · | · | · | $-87M | · | · | · | $-108M | · | · | · | $-93M | · | · | |
| Levered FCF | · | · | · | · | · | $-102M | · | · | · | $-138M | · | · | · | $-123M | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -120.4% | -157.9% | · | -173.5% | -269.8% | -390.1% | · | -1314.3% | -9487.4% | -237990.0% | · | -97726.8% | -207670.7% | -30994.4% | · | -76952.5% | |
| Net Margin | -449.6% | -1431.4% | · | -209.8% | -350.3% | -784.9% | · | -1404.0% | -12852.3% | -335272.5% | · | -116563.4% | -336290.2% | -32317.5% | · | -94015.2% | |
| Pretax Margin | -449.6% | -1431.5% | · | -209.9% | -349.3% | -786.5% | · | -1404.4% | -12854.2% | -335325.0% | · | -116636.6% | -337104.9% | -32384.2% | · | -94204.2% | |
| EBITDA Margin | -120.4% | -148.0% | · | -173.5% | -269.8% | -366.9% | · | -1314.3% | -9487.4% | -226602.5% | · | -97726.8% | -207670.7% | -29694.2% | · | -76952.5% | |
| ROA | -44.7% | -133.2% | · | -15.2% | -21.9% | -36.8% | · | -21.5% | -36.6% | -36.0% | · | -24.3% | -45.3% | -31.7% | · | -39.1% | |
| ROE | 28.5% | 86.6% | · | 10.6% | 14.6% | 20.2% | · | 14.8% | 20.1% | 22.0% | · | 22.8% | 26.0% | 26.9% | · | 36.1% | |
| ROIC | 5.9% | 8.0% | · | 10.6% | 12.5% | 10.9% | · | 10.8% | 14.2% | 13.8% | · | 19.5% | 53.1% | 21.1% | · | 21.3% |
유동성 및 지급능력 4
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 6.7 | · | 5.8 | 4.1 | 2.2 | · | 2.7 | 3.9 | 3.6 | · | 2.4 | 0.1 | 0.2 | · | 2.0 | |
| Quick Ratio | 5.4 | 6.2 | · | 5.1 | 3.5 | 1.6 | · | 2.2 | 3.5 | 3.2 | · | 2.1 | 0.1 | 0.2 | · | 1.6 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | -0.8 | · | · | · | |
| Interest Coverage | · | · | · | -3.6 | -4.6 | -4.2 | · | -2.7 | -3.3 | -3.2 | · | -2.3 | -2.6 | -3.7 | · | -5.4 |
효율성 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.4 | 1.5 | · | 1.8 | 2.3 | 1.9 | · | 2.9 | 1.9 | · | · | · | · | · | · | · |
가치 평가 (TTM) 12
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $154M | $119M | · | $81M | $50M | $24M | · | $7M | $1M | $523.0K | · | $601.0K | $554.0K | $527.0K | · | $233.0K | |
| Net Income TTM | $-1.02B | $-922M | · | $-375M | $-442M | $-484M | · | $-450M | $-502M | $-484M | · | $-461M | $-460M | $-425M | · | $-396M | |
| Market Cap | $9.22B | $8.03B | · | $2.42B | $2.42B | $2.57B | · | $2.59B | $4.37B | $3.64B | · | $1.13B | $1.23B | $767M | · | $1.99B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $939M | $1.66B | · | · | · | |
| P/E | -8.7 | -8.2 | · | -5.3 | -4.5 | -4.4 | · | -5.1 | -6.9 | -5.5 | · | -1.6 | -2.5 | -1.7 | · | -5.0 | |
| P/S | 59.9 | 67.4 | · | 29.9 | 48.3 | 108.4 | · | 356.3 | 3613.3 | 6951.3 | · | 1877.6 | 2211.3 | 1455.9 | · | 8538.7 | |
| P/B | -8.8 | -9.2 | · | -4.6 | -4.2 | -4.3 | · | -3.5 | -6.3 | -5.3 | · | -2.7 | -1.9 | -1.5 | · | -4.7 | |
| P / Cash Flow | · | -106.6 | · | · | · | -29.9 | · | · | · | -34.0 | · | · | · | -9.1 | · | · | |
| P / FCF | · | -104.1 | · | · | · | -29.5 | · | · | · | -33.6 | · | · | · | -8.3 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -11.7 | -19.5 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | 1561.8 | 2998.2 | · | · | · | |
| Earnings Yield | -11.5% | -12.3% | · | -18.7% | -22.4% | -22.9% | · | -19.6% | -14.4% | -18.2% | · | -62.7% | -39.9% | -57.7% | · | -20.1% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $113M | $15M | $622.0K | $240.0K | $934.0K |
| 영업이익률 % | -226.0% | -2334.2% | -58239.5% | -146374.2% | -35361.9% |
| 순이익 | $-351M | $-414M | $-583M | $-417M | $-347M |
| 희석 EPS | $-0.38 | $-0.62 | $-1.15 | $-1.04 | $-0.89 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | — | — | 0.0 | — | — |
| 유동비율 | 5.1 | 3.4 | 5.0 | 0.3 | 0.9 |
| 당좌 비율 | 4.6 | 2.8 | 4.6 | 0.2 | 0.9 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-309M | $-398M | $-397M | $-416M | $-308M |
최신 뉴스 이 회사 관련 최근 헤드라인
- ImmunityBio (IBRX): One of the Best Performing Growth Stocks So Far in 2026
- ImmunityBio Inc. (IBRX): One of the Most Shorted Mid-Cap Stocks to Buy Now
- 왜 ImmunityBio 주식은 오늘 크게 상승하고 있나
- ImmunityBio 주식, 월요일 급락 이유
- ImmunityBio Inc. (IBRX)는 마카오 특별행정구, 중국에서 ANKTIVA®에 대한 승인을 발표했습니다.
- 면역바이오 (IBRX)가 국립종합암네트워크(NCCN) 업데이트 임상실습지침에 유두상 NMIBC 환자를 위한 ANKTIVA 포함 발표
- 오늘의 주식 시장, 3월 24일: 유가, AI, 사모 신용 우려가 시장을 압박
- ImmunityBio 주가가 오늘 20% 이상 하락한 이유
- 짐 크레이머, ImmunityBio에 대해: “그 주식은 마법적 사고 시대의 일부입니다”
- ImmunityBio (IBRX) 17% 하락하여 장중 최고치 경신 후 이익 실현
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 448개의 제출자 · $1.5B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 76 (-92 이전 분기 대비) | 45 (+16 이전 분기 대비) | 134 (+6 이전 분기 대비) | 109 (+41 이전 분기 대비) | +48.6M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| STATE STREET CORP | $187,343,325 | 21,398,438 | 12.68% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $156,398,541 | 17,863,911 | 10.59% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $137,379,774 | 15,691,579 | 9.30% | 주식 |
| D. E. Shaw & Co., Inc. | $101,129,171 | 11,551,019 | 6.85% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $97,155,163 | 11,097,106 | 6.58% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $74,962,230 | 8,560,815 | 5.07% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $58,057,776 | 6,627,600 | 3.93% | 콜 옵션 |
| MILLENNIUM MANAGEMENT LLC | $48,851,088 | 5,579,793 | 3.31% | 주식 |
| LMR Partners LLP | $34,879,045 | 3,983,900 | 2.36% | 콜 옵션 |
| CITADEL ADVISORS LLC | $33,592,060 | 3,836,900 | 2.27% | 콜 옵션 |
| GREAT POINT PARTNERS LLC | $26,272,004 | 3,000,800 | 1.78% | 풋 옵션 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25,289,754 | 2,888,607 | 1.71% | 주식 |
| Woodline Partners LP | $21,889,155 | 2,500,189 | 1.48% | 주식 |
| SEB Asset Management AB | $21,424,757 | 2,447,150 | 1.45% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $21,120,019 | 2,412,338 | 1.43% | 주식 |
| GOLDMAN SACHS GROUP INC | $20,744,372 | 2,369,431 | 1.40% | 주식 |
| JANE STREET GROUP, LLC | $17,547,647 | 2,004,300 | 1.19% | 콜 옵션 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $15,075,252 | 1,721,902 | 1.02% | 주식 |
| CITADEL ADVISORS LLC | $14,898,384 | 1,701,700 | 1.01% | 풋 옵션 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14,700,156 | 1,678,100 | 1.00% | 풋 옵션 |
| BANK OF AMERICA CORP /DE/ | $13,631,448 | 1,556,990 | 0.92% | 주식 |
| UBS Group AG | $12,287,966 | 1,403,537 | 0.83% | 주식 |
| FIRST TRUST ADVISORS LP | $10,634,409 | 1,214,667 | 0.72% | 주식 |
| Cetera Investment Advisers | $9,984,867 | 1,140,476 | 0.68% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $9,012,388 | 1,029,399 | 0.61% | 주식 |
| LPL Financial LLC | $8,939,354 | 1,021,057 | 0.61% | 주식 |
| OSAIC HOLDINGS, INC. | $7,670,411 | 875,621 | 0.52% | 주식 |
| Pictet Asset Management Holding SA | $7,433,121 | 847,659 | 0.50% | 주식 |
| Squarepoint Ops LLC | $6,662,494 | 760,993 | 0.45% | 주식 |
| Swiss National Bank | $6,321,110 | 722,000 | 0.43% | 주식 |
| Clearwater Capital Advisors, LLC | $6,281,923 | 717,524 | 0.43% | 주식 |
| BARCLAYS PLC | $6,115,500 | 698,515 | 0.41% | 주식 |
| Trexquant Investment LP | $6,098,269 | 696,547 | 0.41% | 주식 |
| ALLEN HOLDING INC /NY | $6,019,684 | 687,571 | 0.41% | 주식 |
| Kercheville Advisors, LLC | $5,644,219 | 644,685 | 0.38% | 주식 |
| Voleon Capital Management LP | $4,807,598 | 549,126 | 0.33% | 주식 |
| D.A. DAVIDSON & CO. | $4,718,279 | 538,924 | 0.32% | 주식 |
| CITIGROUP INC | $4,622,334 | 527,965 | 0.31% | 주식 |
| Bank of New York Mellon Corp | $4,511,058 | 515,255 | 0.31% | 주식 |
| SHEETS SMITH WEALTH MANAGEMENT | $4,487,568 | 512,572 | 0.30% | 주식 |
| CenterBook Partners LP | $4,341,972 | 495,942 | 0.29% | 주식 |
| RHUMBLINE ADVISERS | $4,175,557 | 476,935 | 0.28% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $4,045,618 | 527,460 | 0.27% | 주식 |
| Legacy Capital Group California, Inc. | $3,904,730 | 446,000 | 0.26% | 주식 |
| VAN ECK ASSOCIATES CORP | $3,715,913 | 424,191 | 0.25% | 주식 |
| BlackRock, Inc. | $3,563,994 | 407,081 | 0.24% | 주식 |
| CLOUGH CAPITAL PARTNERS L P | $3,495,136 | 399,216 | 0.24% | 주식 |
| Verition Fund Management LLC | $3,349,663 | 382,600 | 0.23% | 풋 옵션 |
| WELLS FARGO & COMPANY/MN | $3,194,095 | 364,831 | 0.22% | 주식 |
| Plancorp, LLC | $3,087,598 | 396,354 | 0.21% | 주식 |
| Rafferty Asset Management, LLC | $3,032,872 | 346,416 | 0.21% | 주식 |
| Clearstead Advisors, LLC | $2,991,680 | 341,711 | 0.20% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2,963,182 | 386,334 | 0.20% | 주식 |
| JANE STREET GROUP, LLC | $2,945,182 | 336,400 | 0.20% | 풋 옵션 |
| MOR Wealth Management, LLC | $2,647,923 | 302,447 | 0.18% | 주식 |
| BANK OF MONTREAL /CAN/ | $2,618,621 | 299,100 | 0.18% | 풋 옵션 |
| Verition Fund Management LLC | $2,469,786 | 282,100 | 0.17% | 콜 옵션 |
| MARSHALL WACE, LLP | $2,413,074 | 275,465 | 0.16% | 주식 |
| NIA IMPACT ADVISORS, LLC | $2,365,310 | 270,167 | 0.16% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $2,338,653 | 267,122 | 0.16% | 주식 |
| Focus Partners Wealth | $2,304,605 | 263,233 | 0.16% | 주식 |
| Winning Points Advisors, LLC | $2,287,314 | 726,258 | 0.15% | 주식 |
| LMR Partners LLP | $2,285,931 | 261,100 | 0.15% | 풋 옵션 |
| TWO SIGMA ADVISERS, LP | $2,261,667 | 1,142,256 | 0.15% | 주식 |
| Headlands Technologies LLC | $2,176,055 | 248,550 | 0.15% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2,133,401 | 243,678 | 0.14% | 주식 |
| BLAIR WILLIAM & CO/IL | $2,118,325 | 241,956 | 0.14% | 주식 |
| TUDOR INVESTMENT CORP ET AL | $1,991,763 | 227,500 | 0.13% | 콜 옵션 |
| MetLife Investment Management, LLC | $1,970,751 | 225,100 | 0.13% | 주식 |
| AQR CAPITAL MANAGEMENT LLC | $1,947,173 | 222,407 | 0.13% | 주식 |
| DARK FOREST CAPITAL MANAGEMENT LP | $1,831,222 | 209,163 | 0.12% | 주식 |
| Carr Financial Group Corp | $1,814,807 | 207,288 | 0.12% | 주식 |
| STATE OF WISCONSIN INVESTMENT BOARD | $1,780,863 | 203,411 | 0.12% | 주식 |
| ExodusPoint Capital Management, LP | $1,692,692 | 193,340 | 0.11% | 주식 |
| Y-Intercept (Hong Kong) Ltd | $1,654,397 | 188,966 | 0.11% | 주식 |
| Corient Private Wealth LP | $1,602,252 | 182,763 | 0.11% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1,558,521 | 178,015 | 0.11% | 주식 |
| PROFUND ADVISORS LLC | $1,545,284 | 176,503 | 0.10% | 주식 |
| Gotham Asset Management, LLC | $1,537,063 | 175,564 | 0.10% | 주식 |
| MFG WEALTH MANAGEMENT, INC. | $1,522,365 | 173,885 | 0.10% | 주식 |
| China Universal Asset Management Co., Ltd. | $1,459,345 | 166,687 | 0.10% | 주식 |
| Private Advisor Group, LLC | $1,452,929 | 165,954 | 0.10% | 주식 |
| Virtus Investment Advisers, LLC | $1,433,946 | 163,786 | 0.10% | 주식 |
| Rathbones Group PLC | $1,428,991 | 163,220 | 0.10% | 주식 |
| Davidson Kahn Capital Management, LLC | $1,427,870 | 163,092 | 0.10% | 주식 |
| SYMMETRY PEAK MANAGEMENT LLC | $1,400,800 | 160,000 | 0.09% | 콜 옵션 |
| Vanguard Global Advisers, LLC | $1,381,478 | 157,793 | 0.09% | 주식 |
| COLLECTIVE FAMILY OFFICE LLC | $1,376,286 | 157,200 | 0.09% | 주식 |
| Invesco Ltd. | $1,335,181 | 152,505 | 0.09% | 주식 |
| HUSSMAN STRATEGIC ADVISORS, INC. | $1,286,985 | 147,000 | 0.09% | 주식 |
| COMMONWEALTH EQUITY SERVICES, LLC | $1,258,229 | 143,716 | 0.09% | 주식 |
| Creative Planning | $1,210,195 | 138,229 | 0.08% | 주식 |
| JANUS HENDERSON GROUP PLC | $1,203,621 | 157,439 | 0.08% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $1,196,219 | 136,632 | 0.08% | 주식 |
| SBI Securities Co., Ltd. | $1,193,490 | 136,321 | 0.08% | 주식 |
| CITADEL ADVISORS LLC | $1,191,074 | 136,045 | 0.08% | 주식 |
| Point72 Asset Management, L.P. | $1,155,660 | 132,000 | 0.08% | 콜 옵션 |
| XTX Topco Ltd | $1,154,942 | 131,918 | 0.08% | 주식 |
| GUGGENHEIM CAPITAL LLC | $1,143,245 | 130,582 | 0.08% | 주식 |
| Bleakley Financial Group, LLC | $1,132,731 | 129,381 | 0.08% | 주식 |
회사 내부자 20 명의 내부자 · 4 임원 · 12 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Sonja Nelson | Chief Financial Officer | 2021년 1월 12일 M | 15,410 | 0 | 0 | $0 |
| Richard J. Tajak | Chief Financial Officer | 2017년 3월 23일 M | 12,876 | 0 | 0 | $0 |
| Angela Wilson | Chief Financial Officer | 2015년 12월 10일 P | 3,265 | 0 | 0 | $0 |
| Regan J Lauer | Chief Accounting Officer | 2026년 2월 22일 M | 115,875 | 0 | 0 | $0 |
| Cheryl Cohen | 이사 | 2026년 7월 2일 M | 125,386 | 0 | 1 | $-1,246,495 |
| Christobel Selecky | 이사 | 2026년 7월 1일 M | 0 | 0 | 3 | $-2,309,947 |
| Barry J. Simon | 이사 | 2026년 6월 24일 S | 2,802,788 | 0 | 2 | $-362,306 |
| Linda Maxwell | 이사 | 2026년 6월 9일 A | — | 0 | 0 | $0 |
| Michael D Blaszyk | 이사 | 2026년 6월 9일 A | 71,915 | 0 | 0 | $0 |
| Bruce Wendel | 이사 | 2026년 6월 9일 A | — | 0 | 0 | $0 |
| Wesley Clark | 이사 | 2026년 6월 9일 A | 8,000 | 0 | 0 | $0 |
| John C Thomas | 이사 | 2020년 12월 10일 S | 207,477 | 0 | 0 | $0 |
| Frederick W Driscoll | 이사 | 2020년 8월 11일 S | 109,235 | 0 | 0 | $0 |
| Steve Gorlin | 이사 | 2020년 6월 10일 A | 92,592 | 0 | 0 | $0 |
| Richard Kusserow | 이사 | 2017년 6월 9일 A | 394,053 | 0 | 0 | $0 |
| John T Potts JR | 이사 | 2017년 6월 9일 A | 159,253 | 0 | 0 | $0 |
| David C. Sachs | — | 2025년 2월 22일 M | 225,620 | 0 | 0 | $0 |
| Richard Adcock | — | 2025년 2월 22일 M | 334,418 | 0 | 0 | $0 |
| Patrick Soon-Shiong | — | 2025년 2월 10일 A | — | 0 | 0 | $0 |
| John Owen Brennan | — | 2024년 6월 11일 A | 25,000 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 2 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Cambridge Equities, LP, MP 13 Ventures, LLC, NantWorks, LLC, Nant Capital, LLC, California Capital Equity, LLC, Patrick Soon-Shiong ×5 제출 서류 | 2026년 8월 6일 | 64.80% | 수정본 | — | SEC |
| Cambridge Equities, LP (2), MP 13 Ventures, LLC (2), NantWorks, LLC (2), NantMobile, LLC (2), Nant Capital, LLC (2), California Capital Equity, LLC (2), Patrick Soon-Shiong (2) ×9 제출 서류 | 2024년 1월 4일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 48 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 4.80% | 401,005 NS | 2026년 4월 30일 | N-PORT |
| IDNA · iShares Trust | 3.03% | 817,183 SH | 2026년 8월 8일 | 일간 |
| LABU · Direxion Shares ETF Trust | 0.80% | 587,041 NS | 2026년 4월 30일 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.61% | 446,981 NS | 2026년 4월 30일 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.55% | 56,995 SH | 2026년 8월 8일 | 일간 |
| BIB · ProShares Trust | 0.39% | 38,008 NS | 2026년 5월 31일 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.32% | 593,103 NS | 2026년 4월 30일 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0.25% | 91,038 NS | 2026년 5월 31일 | N-PORT |
| IBB · iShares Trust | 0.21% | 2,767,182 SH | 2026년 8월 8일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.20% | 414,467 SH | 2026년 8월 8일 | 일간 |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.18% | 122,888 NS | 2026년 4월 30일 | N-PORT |
| IWO · iShares Trust | 0.17% | 3,501,087 SH | 2026년 8월 8일 | 일간 |
| VFMO · VANGUARD WELLINGTON FUND | 0.17% | 390,556 SH | 2026년 8월 8일 | 일간 |
| GINN · Goldman Sachs ETF Trust | 0.13% | 38,134 NS | 2026년 5월 31일 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.12% | 128,026 NS | 2026년 4월 30일 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.10% | 11,949 NS | 2026년 4월 30일 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.10% | 2,224,716 SH | 2026년 8월 8일 | 일간 |
| VBK · VANGUARD INDEX FUNDS | 0.09% | 4,852,894 SH | 2026년 8월 8일 | 일간 |
| IWM · iShares Trust | 0.09% | 9,756,233 SH | 2026년 8월 8일 | 일간 |
| ISCG · iShares Trust | 0.09% | 118,645 SH | 2026년 8월 8일 | 일간 |
| RSSL · Global X Funds | 0.06% | 127,814 NS | 2026년 4월 30일 | N-PORT |
| TECB · iShares Trust | 0.06% | 36,976 SH | 2026년 8월 8일 | 일간 |
| ITWO · ProShares Trust | 0.06% | 13,888 NS | 2026년 5월 31일 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.05% | 1,082,841 SH | 2026년 8월 8일 | 일간 |
| SCHA · SCHWAB STRATEGIC TRUST | 0.05% | 1,465,790 NS | 2026년 5월 31일 | N-PORT |
| ESML · iShares Trust | 0.04% | 172,627 SH | 2026년 8월 8일 | 일간 |
| ISCB · iShares Trust | 0.04% | 17,015 SH | 2026년 8월 8일 | 일간 |
| VB · VANGUARD INDEX FUNDS | 0.04% | 8,407,771 SH | 2026년 8월 8일 | 일간 |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 158,131 NS | 2026년 4월 30일 | N-PORT |
| UWM · ProShares Trust | 0.03% | 10,862 NS | 2026년 5월 31일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 3,724,582 SH | 2026년 8월 8일 | 일간 |
| URTY · ProShares Trust | 0.02% | 10,994 NS | 2026년 5월 31일 | N-PORT |
| WSML · iShares Trust | 0.02% | 20,064 SH | 2026년 8월 8일 | 일간 |
| ONEQ · Fidelity Commonwealth Trust | 0.02% | 243,104 NS | 2026년 5월 31일 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.02% | 20,738 NS | 2026년 5월 31일 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 11,550 NS | 2026년 5월 31일 | N-PORT |
| SMLF · iShares Trust | 0.01% | 57,350 SH | 2026년 8월 8일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 36,936 SH | 2026년 8월 8일 | 일간 |
| HDG · ProShares Trust | 0.01% | 276 NS | 2026년 5월 31일 | N-PORT |
| GUSA · Goldman Sachs ETF Trust II | 0.00% | 12,568 NS | 2026년 5월 31일 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 11,088 NS | 2026년 4월 30일 | N-PORT |
| IWV · iShares Trust | 0.00% | 104,600 SH | 2026년 8월 8일 | 일간 |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.00% | 1,163 NS | 2026년 5월 31일 | N-PORT |
| ITOT · iShares Trust | 0.00% | 437,756 SH | 2026년 8월 8일 | 일간 |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 172,180 NS | 2026년 5월 31일 | N-PORT |
| AVLC · AMERICAN CENTURY ETF TRUST | 0.00% | 2,426 NS | 2026년 5월 31일 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 11,599,962 SH | 2026년 8월 8일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 31,790 SH | 2026년 8월 8일 | 일간 |